GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Ipca Laboratories Ltd (BOM:524494) » Definitions » Other Income (Expense)

Ipca Laboratories (BOM:524494) Other Income (Expense) : ₹170 Mil (TTM As of Mar. 2024)


View and export this data going back to 1994. Start your Free Trial

What is Ipca Laboratories Other Income (Expense)?

Ipca Laboratories's other income expense for the Ipca Laboratories's pretax income for the three months ended in Mar. 2024 was ₹-1,568 Mil. Its other income expense for the trailing twelve months (TTM) ended in Mar. 2024 was ₹170 Mil.

Ipca Laboratories Other Income (Expense) Historical Data

The historical data trend for Ipca Laboratories's Other Income (Expense) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Ipca Laboratories Other Income (Expense) Chart

Ipca Laboratories Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Other Income (Expense)
Get a 7-Day Free Trial Premium Member Only Premium Member Only -183.10 462.80 500.90 1,256.20 170.20

Ipca Laboratories Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Other Income (Expense) Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 363.90 448.50 385.50 904.60 -1,568.40

Ipca Laboratories Other Income (Expense) Calculation

Other income expense includes minority interest. Minority interest is a significant but non-controlling ownership of less than 50% of a company's voting shares by either an investor or another company.

Other Income (Expense) for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹170 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Ipca Laboratories  (BOM:524494) Other Income (Expense) Explanation

Minority interest is reported on the consolidated income statement as a share of profit belonging to minority shareholders.

Ipca Laboratories (BOM:524494) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Ipca Laboratories Ltd (BOM:524494) » Definitions » Other Income (Expense)
Comparable Companies
BOM:532331 BOM:506943 BOM:532296 BOM:540222 BOM:533573 BOM:524816 BOM:543064 BOM:543635 BOM:506820 BOM:540596 ZTS XTER:MRK TSE:4502 LSE:HLN NSE:SUNPHARMA TSE:4523 TSE:4507 SZSE:000538 XSWX:SDZ HKSE:03692
Traded in Other Exchanges
IPCALAB:India
Address
125, Kandivli Industrial Estate, Kandivli (West), Mumbai, MH, IND, 400067
Website
https://www.ipca.com
Ipca Laboratories Ltd is a specialty and generic drug manufacturing company. The company's principal activity is Development, Manufacturing and Marketing of Pharmaceuticals Products. The company operates multiple subsidiaries with revenue generation split roughly between India and the rest of the world. Ipca's products are exported to more than 100 countries across the globe. Ipca has only one reportable primary business segment, pharmaceuticals.

Ipca Laboratories (BOM:524494) Headlines

No Headlines